Response to the letter to the Editor concerning manuscript entitled, “Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide”
Saved in:
Published in | Supportive care in cancer Vol. 28; no. 12; pp. 5591 - 5592 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.12.2020
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
ISSN: | 0941-4355 1433-7339 |
---|---|
DOI: | 10.1007/s00520-020-05726-0 |